San Diego, CA -- (SBWire) -- 02/06/2023 --The Shareholders Foundation announced that a deadline is coming up on February 6, 2023 in the lawsuit filed for certain investors of NeoGenomics, Inc. (NASDAQ: NEO).
Investors who purchased shares of NeoGenomics, Inc. (NASDAQ: NEO) have certain options and there are strict and short deadlines running. Deadline: February 6, 2023. NASDAQ: NEO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of NeoGenomics, Inc. (NASDAQ: NEO) common shares, that NeoGenomics and certain members of its management misrepresented and/or failed to disclose that NeoGenomics was not a "one-stop shop" for cancer testing which led to a significant decrease in revenue as current and prospective customers went elsewhere for their testing needs, that the Company's costs were not fixed because NeoGenomics needed to hire additional employees to process more complex customized testing demanded by customers utilizing the Company's outdated portfolio of tests, leading to operational challenges, decreased lab efficiency, and increased testing turnaround times, and that NeoGenomics violated federal healthcare laws and regulations related to fraud, waste, and abuse.
Those who purchased shares of NeoGenomics, Inc. (NASDAQ: NEO) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NeoGenomics, Inc. (NASDAQ:NEO) Investor Notice: Deadline in Lawsuit on February 6, 2023
A Deadline is coming up on February 6, 2023 in the lawsuit for certain investors in NeoGenomics, Inc. (NASDAQ:NEO).